ArticleJAMA network open2021

Trends in Use of Granulocyte Colony-Stimulating Factor Following Introduction of Biosimilars Among Adults With Cancer and Commercial or Medicare Insurance From 2014 to 2019.

Ching-Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.